These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 12487364
1. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs). O'Connor JC, Cook JC, Marty MS, Davis LG, Kaplan AM, Carney EW. Crit Rev Toxicol; 2002; 32(6):521-49. PubMed ID: 12487364 [Abstract] [Full Text] [Related]
2. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Owens JW, Ashby J. Crit Rev Toxicol; 2002; 32(6):445-520. PubMed ID: 12487363 [Abstract] [Full Text] [Related]
4. Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. O'Connor JC, Davis LG, Frame SR, Cook JC. Toxicol Sci; 2000 Apr; 54(2):338-54. PubMed ID: 10774816 [Abstract] [Full Text] [Related]
5. An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs). O'Connor JC, Cook JC, Slone TW, Makovec GT, Frame SR, Davis LG. Toxicol Sci; 1998 Nov; 46(1):45-60. PubMed ID: 9928668 [Abstract] [Full Text] [Related]
6. Sensitivity of a Tier I screening battery compared to an in utero exposure for detecting the estrogen receptor agonist 17 beta-estradiol. O'Connor JC, Frame SR, Biegel LB, Cook JC, Davis LG. Toxicol Sci; 1998 Aug; 44(2):169-84. PubMed ID: 9742655 [Abstract] [Full Text] [Related]
7. Detection of dopaminergic modulators in a tier I screening battery for identifying endocrine-active compounds (EACs). O'Connor JC, Davis LG, Frame SR, Cook JC. Reprod Toxicol; 2000 Aug; 14(3):193-205. PubMed ID: 10838120 [Abstract] [Full Text] [Related]
14. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals. Ankley GT, Gray LE. Environ Toxicol Chem; 2013 Apr; 32(5):1084-7. PubMed ID: 23401061 [Abstract] [Full Text] [Related]
17. Answering the endocrine test questions. Schmidt CW. Environ Health Perspect; 1999 Sep; 107(9):A458-60. PubMed ID: 10464085 [Abstract] [Full Text] [Related]
18. Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity. Naciff JM, Daston GP. Toxicol Pathol; 2004 Sep; 32 Suppl 2():59-70. PubMed ID: 15503665 [Abstract] [Full Text] [Related]
19. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee. Stoker TE, Parks LG, Gray LE, Cooper RL. Crit Rev Toxicol; 2000 Mar; 30(2):197-252. PubMed ID: 10759431 [Abstract] [Full Text] [Related]
20. Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results. Borgert CJ, Mihaich EM, Quill TF, Marty MS, Levine SL, Becker RA. Regul Toxicol Pharmacol; 2011 Apr; 59(3):397-411. PubMed ID: 21251942 [Abstract] [Full Text] [Related] Page: [Next] [New Search]